Cargando…
Will another trial CONVINCE nephrologists to adopt high-dose haemodiafiltration over conventional haemodialysis?
Autores principales: | Mayne, Kaitlin J, Ronco, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689160/ https://www.ncbi.nlm.nih.gov/pubmed/38046007 http://dx.doi.org/10.1093/ckj/sfad258 |
Ejemplares similares
-
Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol
por: Blankestijn, Peter J, et al.
Publicado: (2020) -
CONVINCE in the context of existing evidence on haemodiafiltration
por: Vernooij, Robin W M, et al.
Publicado: (2022) -
Online-haemodiafiltration vs. conventional haemodialysis: a cross-over study
por: Jean, Guillaume, et al.
Publicado: (2015) -
Kidney stones and thiazide diuretics: revisiting old assumptions in light of the NOSTONE trial
por: Cirillo, Luigi, et al.
Publicado: (2023) -
High dose haemodialysis and haemodiafiltration parameters and the relationship with advanced vascular calcification
por: Park, Sung Keun, et al.
Publicado: (2020)